Analysis of integrated clinical trial protocols in early phases of medicinal product development.

When analysing the duration until initial authorisation of a clinical trial application (CTA) over the last 10 years, it became obvious that there was a significant trend towards shorter approval times for non-integrated protocols ( r = − 0.76; p = 0.007, Fig. 4 a).

also in 9,775 other papers